| Product Name | MF | CAS | Details |
|---|
| RAF1 KINASE INHIBITOR I | C15H8Br2INO2 | 220904-83-6 | Details |
| Nimesulide | C13H12N2O5S | 51803-78-2 | Details |
| CGS 21680A | C23H30ClN7O6 | 124431-80-7 | Details |
| cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid | C21H21ClF2O4S | 471905-41-6 | Details |
| BMS-794833 | C23H15ClF2N4O3 | 1174046-72-0 | Details |
| VRT752271 | C21H22Cl2N4O2 | 869886-67-9 | Details |
| ARG-GLY-ASP | C12H22N6O6 | 99896-85-2 | Details |
| Clomifene citrate | C32H36ClNO8 | 50-41-9 | Details |
| M344 | C16H25N3O3 | 251456-60-7 | Details |
| Ribavirin | C8H12N4O5 | 36791-04-5 | Details |
| N-(2-METHYL-6-BENZOOXAZOLYL)-N''-1,5-NAPHTHYRIDIN-4-YL UREA | C17H13N5O2 | 792173-99-0 | Details |
| CRA-02478 | C21H23N3O5 | 783355-60-2 | Details |
| LY 2874455 | C21H19Cl2N5O2 | 1254473-64-7 | Details |
| IKK Inhibitor III, BMS-345541 | C14H17N5 | 445430-58-0 | Details |
| CEP-32496 (free base) | C24H22F3N5O5 | 1188910-76-0 | Details |
| AZD5363 | C21H25ClN6O2 | 1143532-39-1 | Details |
| ML-323 | C23H24N6 | 1572414-83-5 | Details |
| N-(4-Mesitylthiazol-2-yl)benzaMide | C19H18N2OS | 1001753-24-7 | Details |
| Oxaprozin | C18H15NO3 | 21256-18-8 | Details |
| PP2 | C15H16ClN5 | 172889-27-9 | Details |
| Ampiroxicam | C20H21N3O7S | 99464-64-9 | Details |
| AKTI-1/2 | C34H29N7O | 612847-09-3 | Details |
| Indometacin | C19H16ClNO4 | 53-86-1 | Details |
| 1-(3,4-DICHLOROBENZYL)-1H-INDOLE-2,3-DIONE | C15H9Cl2NO2 | 79183-19-0 | Details |
| (+)-Griseofulvin | C17H17ClO6 | 126-07-8 | Details |
| HA14-1 | C17H17BrN2O5 | 65673-63-4 | Details |
| Droxinostat | C11H14ClNO3 | 99873-43-5 | Details |
| Butanoic acid, 4-[(5-bromo-2-pyridinyl)amino]-4-oxo- | C9H9BrN2O3 | 188011-69-0 | Details |
| (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1) | C32H30FN3O10 | 1140909-48-3 | Details |
| OSI-420 | C21H22ClN3O4 | 183320-51-6 | Details |
| LMK-235 | C15H22N2O4 | 1418033-25-6 | Details |
| 4SC-202 (free base) | C23H21N5O3S | 910462-43-0 | Details |
| UNC2025 | C28H40N6O | 1429881-91-3 | Details |
| PLX3397 (Pexidartinib) | C20H15ClF3N5 | 1029044-16-3 | Details |
| Dolasteron | C14H12O3S | 40828-46-4 | Details |
| Neratinib | C30H29ClN6O3 | 698387-09-6 | Details |
| NOCODAZOLE | C14H11N3O3S | 31430-18-9 | Details |
| 2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO- | C20H17Cl2N9O2 | 252935-94-7 | Details |
| PF-05212384 | C32H41N9O4 | 1197160-78-3 | Details |
| XL518 | C21H21F3IN3O2 | 934660-93-2 | Details |
| (S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one | C23H30N8O3S | 1032754-93-0 | Details |
| N-Hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide hydrochloride | C20H22ClN3O2 | 1310693-92-5 | Details |
| N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE | C15H14N2O4S | 414864-00-9 | Details |
| SCR7 | C18H14N4OS | 1533426-72-0 | Details |
| AMG319 | C21H16FN7 | 1608125-21-8 | Details |
| MG-132 | C26H41N3O5 | 133407-82-6 | Details |
| Ketoprofen | C16H14O3 | 22071-15-4 | Details |
| Niflumic acid | C13H9F3N2O2 | 4394-00-7 | Details |
| TPCA-1 | C12H10FN3O2S | 507475-17-4 | Details |
| PUROMYCIN DIHYDROCHLORIDE | C22H30ClN7O5 | 58-58-2 | Details |
| SL 327 | C16H12F3N3S | 305350-87-2 | Details |
| Progesterone | C21H30O2 | 57-83-0 | Details |
| Unii-33Y9anm545 | C21H24ClN7O2S | 635702-64-6 | Details |
| SGX-523 | C18H13N7S | 1022150-57-7 | Details |
| 1-[1-(4-Fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)ethanone | C18H21FN2O | 314245-33-5 | Details |
| A66 | C17H23N5O2S2 | 1166227-08-2 | Details |
| 6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine | C18H21IN6O2S | 873436-91-0 | Details |
| KRN 633 | C20H21ClN4O4 | 286370-15-8 | Details |
| CAY10603 | C22H30N4O6 | 1045792-66-2 | Details |
| R428 | C30H34N8 | 1037624-75-1 | Details |
| PI3K/HDAC Inhibitor | C23H24N8O4S | 1339928-25-4 | Details |
| Gemcitabine | C9H11F2N3O4 | 95058-81-4 | Details |
| CALPEPTIN | C20H30N2O4 | 117591-20-5 | Details |
| VALDECOXIB | C16H14N2O3S | 181695-72-7 | Details |
| Acetylsalicylic acid | C9H8O4 | 50-78-2 | Details |
| Telatinib | C20H16ClN5O3 | 332012-40-5 | Details |
| TICAGRELOR | C23H28F2N6O4S | 274693-27-5 | Details |
| Cyclosporin A | C62H111N11O12 | 59865-13-3 | Details |
| CCG-1423 | C18H13ClF6N2O3 | 285986-88-1 | Details |
| CP-724714 | C27H27N5O3 | 537705-08-1 | Details |
| GDC-0068 | C24H32ClN5O2 | 1001264-89-6 | Details |
| NVP-BVU 972 | C20H16N6 | 1185763-69-2 | Details |
| REVERSINE | C21H27N7O | 656820-32-5 | Details |
| Flunixin meglumin | C21H28F3N3O7 | 42461-84-7 | Details |
| BAM7 | C21H19N5O2S | 331244-89-4 | Details |
| ABT-199 | C45H50ClN7O7S | 1257044-40-8 | Details |
| TP0903 | C24H30ClN7O2S | 1341200-45-0 | Details |
| 4-(4-Methyl-1-piperazinyl)-7-nitrobenzofurazane 3-oxide | C11H13N5O4 | 58131-57-0 | Details |
| (S)-1-((S)-2-(4-amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)pyrrolidine-2-carboxamide | C24H33ClN4O6 | 273404-37-8 | Details |
| Benzonitrile, 3-[1,6-Dihydro-1-[[3-[5-[(1-Methyl-4-Piperidinyl)Methoxy]-2-PyriMidinyl]Phenyl]Methyl]-6-Oxo-3-Pyridazinyl] | C29H28N6O2 | 1100598-32-0 | Details |
| U0126-EtOH | C20H22N6OS2 | 1173097-76-1 | Details |
| Eptifibatide | C35H49N11O9S2 | 148031-34-9 | Details |
| Bufexamac | C12H17NO3 | 2438-72-4 | Details |
| 4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzonitrile | C22H18N6 | 500287-72-9 | Details |
| Y27632 (hydrochloride) | C14H23Cl2N3O | 129830-38-2 | Details |
| WP1130 | C19H18BrN3O | 856243-80-6 | Details |
| TRICHOSTATIN A | C17H22N2O3 | 58880-19-6 | Details |
| ConMana | C22H21N3O4 | 610798-31-7 | Details |
| BRD73954 | C16H16N2O3 | 1440209-96-0 | Details |
| Mycophenolic acid | C17H20O6 | 24280-93-1 | Details |
| Halcinonide | C24H32ClFO5 | 3093-35-4 | Details |
| Gemfibrozil | C15H22O3 | 25812-30-0 | Details |
| SAG | C28H28ClN3OS | 912545-86-9 | Details |
| Sorafenib tosylate | C21H16ClF3N4O3 | 284461-73-0 | Details |
| IKK 16 | C28H29N5OS | 873225-46-8 | Details |
| CNX-2006 | C26H27F4N7O2 | 1375465-09-0 | Details |
| b-AP15 | C22H17N3O6 | 1009817-63-3 | Details |
| Erlotinib | C22H23N3O4 | 183321-74-6 | Details |
| AR-A014418 | C12H12N4O4S | 487021-52-3 | Details |
| 6-METHYLAMINOPURINE 9-RIBOFURANOSIDE | C11H15N5O4 | 1867-73-8 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 | ||||